Iron-dependent ferroptosis in cardiac microvascular endothelial cells: a key link between dysregulated iron homeostasis and microcirculatory injury during myocardial ischemia-reperfusion - Top-Institutions - MDSpire

Iron-dependent ferroptosis in cardiac microvascular endothelial cells: a key link between dysregulated iron homeostasis and microcirculatory injury during myocardial ischemia-reperfusion

  • By

  • Xiaoya Li

  • Qingbo Shi

  • Zhiqiang Wang

  • Zhiwen Zhang

  • Muwei Li

  • May 7, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Cardiology

  • #2

    Columbia University Irving Medical Center/NewYork-Presbyterian Hospital
    Columbia University Irving Medical Center/NewYork-Presbyterian Hospital

    New York, New York

    Key Differentiators

    • Cardiology

  • #3

    CONDI2/ERIC-PPCI trial
    CONDI2/ERIC-PPCI trial

    N/A, N/A

    Key Differentiators

    • Cardiology

  • #4

    Cochin Hospital
    Cochin Hospital

    Paris, France

    Key Differentiators

    • Cardiology

  • #5

    Inserm
    Inserm

    Paris, France

    Key Differentiators

    • Cardiology

Original Source(s)

Iron-dependent ferroptosis in cardiac microvascular endothelial cells: a key link between dysregulated iron homeostasis and microcirculatory injury during myocardial ischemia-reperfusion

  • by Xiaoya Li, Qingbo Shi, Zhiqiang Wang, Zhiwen Zhang, Muwei Li

  • May 7, 2026

Related Content

Flu Vaccination Linked to Lower Heart, Stroke Risk After Infection

A Danish registry study suggests prior influenza vaccination is associated with lower short-term cardiovascular risk following breakthrough infection.

Most Decline Proactive Care Coordination

"Lack of effective communication across physicians is a health system problem."

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.